Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Seviteronel-D (Seivteronel in combination with dexamethasone)|DRUG: Docetaxel
Sponsor: St Vincent's Hospital, Sydney